Abstract:Introduction: A novel formulation that combines IFN alpha-2b and gamma evidenced effectivity in cancer treatment. The poor prognosis of advanced renal cancer needs new therapeutic approaches. A retrospective study was carried out evaluating the effectivity and safety of interferon’s combination in patients with advanced renal cell carcinoma. Methods: Retrospective case-control and cohort analyzes were performed, carried out to identify patients with advanced or metastatic kidney tumors treated from May 2009 … Show more
Set email alert for when this publication receives citations?
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.